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Brief CommunicationLiver-speciﬁc RORa deletion does not affect the
metabolic susceptibility to western style diet
feedingAntonio Molinaro 1, Robert Caesar 1, Laurent L’homme 2, Ara Koh 1, Marcus Ståhlman 1, Bart Staels 2,
Fredrik Bäckhed 1,3,*ABSTRACT
Objectives: The nuclear receptor superfamily is a potential target for the development of new treatments for obesity and metabolic diseases.
Increasing evidence has pointed towards the retinoic acid-related orphan receptor-alpha (RORa) as an important nuclear receptor involved in
several biological processes. RORa full body knockout mice display improved metabolic phenotypes on both chow and high fat (60% fat, 20%
carbohydrate) diets, but also have severe behavioral abnormalities. Here we investigated the effect of hepatic RORa by generating mice with liver-
speciﬁc RORa deletion to elucidate the role of this nuclear receptor on host metabolism.
Methods: 8 week-old mice with liver-speciﬁc RORa deletion and littermate controls were fed either chow or western-style diets (40% fat, 40%
carbohydrate) for 12 weeks. Metabolic phenotyping was performed at the end of the dietary intervention.
Results: Here, we show that hepatic RORa deletion does not affect the metabolic susceptibility to either chow or western-style diet in terms of
glucose metabolism and adiposity.
Conclusions: Our data indicate that liver deletion of RORa does not have a pivotal role in the regulation of hepatic glucose and lipid metabolism
on chow or western-style diet.
 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The incidence of obesity and metabolic associated disorders, such
as cardiovascular diseases, type 2 diabetes mellitus and non-
alcoholic fatty liver disease (NAFLD), increase worldwide [1e3].
Furthermore, there are no effective long-term non-surgical treat-
ments for obesity and metabolic associated disorders [4]. How-
ever, accumulating evidence points towards nuclear receptors
(NRs) as potential molecular treatment targets [5,6]. The NRs
superfamily comprises 48 transcription factors in humans, which
are involved in the regulation of a wide range of physiologic and
pathophysiologic processes (i.e. development, circadian rhythm,
response to steroid hormones, inﬂammation, obesity, diabetes,
NAFLD, and cancer) [7e10].
The retinoic acid-related orphan receptor a (RORa; NR1F1) is a NR
that has been implicated in the regulation of a wide variety of
metabolic pathways, including lipid, glucose and steroid metabolism
[11e13]. The initial indications that RORa can affect metabolic
processes originate mainly from a natural occurring mutant mouse,
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associated complications (i.e., adipose tissue inﬂammation, NAFLD,
and impaired glucose metabolism), but also have cerebral pheno-
types including impaired locomotion [15,16]. However, activation of
RORa with synthetic ligands also improves NAFLD by reducing he-
patic oxidative stress and inﬂammation suggesting a potential
beneﬁcial role of RORa activation on obesity and metabolic diseases
[17e19].
In order to elucidate the role of RORa in obesity and metabolic dis-
eases, tissue speciﬁc knockout models have recently been developed.
Liver-speciﬁc ablation of RORa deteriorates metabolic proﬁle in terms
of adiposity, liver steatosis, inﬂammation and hepatic insulin resis-
tance, when mice were fed a high fat diet (60% of energy from fat and
20% from carbohydrates) [20,21]. These ﬁndings suggest a central
role of RORa in the regulation of hepatic lipid and glucose metabolism.
To further extend and validate the role of RORa on glucose and lipid
metabolism, we generated an independent liver-speciﬁc RORa deﬁ-
cient strain that was metabolically phenotyped on both chow and
western-style diet (WSD; 40% of energy from fat and 40% from car-
bohydrate and 20% protein).ademy, University of Gothenburg, 413 45, Gothenburg, Sweden 2Univ. Lille, Inserm,
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2. MATERIALS AND METHODS
2.1. Mice experiments
Mice harbouring loxP sequences ﬂanking exon 3, the ﬁrst common
exon coding for both isoform 1 and 4, were generated (Figure 1A).
Deletion of the 86 bp exon 3 led to a frame shift resulting in a pre-
mature stop codon. Potential translated truncated proteins would be
composed of 88 and 32 amino acids instead of 523 and 467 for
isoform, 1 and 4 respectively. No functional domain would be present
on these putative proteins. Generation of the strain was completed by
homologous recombination in C57BL/6J embryonic stem cells followed
by microinjection into C57BL/6J blastocysts. The resulting new-borns
were crossed with C57BL/6 Flp delete mice to allow the excision of the
neomycin selection cassette.
Albumin-Cre mice were purchased from The Jackson Laboratory. Cre
efﬁcacy and speciﬁcity towards hepatocytes was conﬁrmed by
breading the mice with ROSAmT/mG mice (data not shown). 8-weeks
old male RORaLKO and RORaﬂ/ﬂ littermate were fed a chow diet
(Labdiet) or WSD (Harland, TD.96132, 40% fat, 40% sugar, 20%
proteins) ad libitum for 12 weeks. MRI, insulin, glucose and pyruvate
tolerance tests, and measurements of insulin levels were performed as
earlier described [22]. Brieﬂy, insulin, glucose and pyruvate tolerance
tests were performed by injecting insulin (0.75 U/kg body weight),
glucose (2 g/kg body weight) or pyruvate (2 g/kg weight) respectively,
intraperitoneally after a 4 (ITT and GTT) or 12 (PTT) h fast. Tail blood
samples were collected at 0, 15, 30, 60, 90 and 120 min and blood
glucose levels were determined using a glucose meter (Accu-Check
Aviva, Roche). Insulin was measured with ELISA (Crystal Chem) ac-
cording to the manufacturers’ protocols. All experiments including
tissue harvesting were performed at the same time of the day (12.00
PM). The local ethics committee in Gothenburg approved all animal
experiments.Figure 1: Generation of liver-speciﬁc RORa knock out mice. Schematic representatio
level of Rora in the liver, ileum, white adipose tissue (WAT), and brain in RORaﬂ/ﬂ and ROR
extract from RORaﬂ/ﬂ and RORaLKO mice (C). Data are plotted as mean e SEM. ***p <
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Lipids were extracted using the BUME method [23]. The cholesteryl
esters, triglycerides and free cholesterol were analyzed using straight
phase HPLC coupled to evaporative light scattering detection according
to previous work [24]. Brieﬂy, the extract was evaporated under ni-
trogen and reconstituted in 500 ml heptane:isopropanol [9:1]. Cho-
lesteryl esters, triglycerides, and free cholesterol were separated using
straight-phase HPLC (Sunﬁre 2.1  100 mm, Waters) coupled to an
evaporative light-scattering detector (PL-ELS 1000, Polymer Labora-
tories), as described previously [24]. Quantiﬁcation was made using
external standards (Larodan Fine Chemicals).
2.3. Primary hepatocytes
Primary hepatocyteswere isolated fromRORaLKO and RORaﬂ/ﬂ littermates
mice by digesting liver with perfusion of collagenase type IV, as described
previously [25]. After perfusion, 16 105 cells were plated on collagen-
coated 60 mm dishes in Dulbecco’s modiﬁed Eagle’s medium (DMEM)/
F12 (Thermo Fisher) supplemented with fetal bovine serum (Thermo
Fisher), penicillin/streptomycin, and 100 nM dexamethasone (Sigma
Aldrich). After 4 h, the medium was changed to DMEM/F12 containing
penicillin/streptomycin and then cells were harvested after 18h.
2.4. Preparation of protein extracts and immunoblotting
RORa deletion in the liver was evaluated by extracting proteins from
the snap-frozen liver or primary cells with lysis buffer, as described
previously [26] and immunoblotting with anti-RORa (Abcam, ab60134,
1:300 dilution), GADPH (Cell Signaling #2118, 1:1000 dilution), and
anti-actin (Cell Signaling #4970, 1:1000 dilution) antibody.
2.5. Quantitative RT-PCR
Total RNA was isolated using RNeasy kit with DNase treatment (Qia-
gen) and cDNA templates were generated using the high-capacityn of the Rora gene-targeting strategy (A, see methods section for details). Expression
aLKO mice (B, 3e8 mice per group). Protein expression level of RORa and actin in liver
0.001.
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Figure 2: RORa hepatic deletion does not affect glucose and lipid metabolism in mice fed chow diet. Body weight (A), body composition (B), relative organ weights (C), liver
cholesterol, cholesteryl esters, triglycerides levels (D), fasting glucose (E) and insulin levels (F), intraperitoneal glucose (G), insulin (H), and pyruvate (I) tolerance test in RORaﬂ/ﬂ and
RORaLKO male mice fed 12 weeks chow diet (n ¼ 7e8 mice per group). Data are plotted as mean e SEM.
Brief CommunicationcDNA reverse transcription kit using random hexamers (Applied Bio-
systems). qRT-PCR assays were performed in 10 ml reactions with
SYBR Green Master Mix buffer (Thermo Scientiﬁc). Gene expression
data were normalized to the ribosomal protein L32. Primer sequences
used are listed in Supplementary Table 1 (SigmaeAldrich).
2.6. Statistical analysis
Data are presented as mean - SEM. Analyses between groups were
performed by Student’s t-test using GraphPad Prism 7 software.
3. RESULTS
3.1. Generation of mice with a hepatocyte speciﬁc RORa deletion
We generated mice with a hepatocyte speciﬁc Rora deletion of by
introducing loxP sites ﬂanking exon 3 of the Rora allele and crossing
them with mice expressing Cre under the albumin promotor (Figure 1A
and Supplementary Fig. 1A).84 MOLECULAR METABOLISM 23 (2019) 82e87  2019 The Authors. Published by Elsevier GmbH. T
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adipose tissue (WAT), and brain, as well as RORa protein levels by
Western blotting, conﬁrmed a selective and speciﬁc liver deletion in
RORaLKO mice compared to littermate RORaﬂ/ﬂ mice (Figure 1BeC).
Liver RT-qPCR analysis showed that there was a trend (p ¼ 0.057)
towards a compensatory increased expression of Rorc by the selective
and speciﬁc liver RORa deletion (Supplementary Fig. 1B). Rorb was not
detectable in the livers (data not shown). Moreover, the expression of
Rev-erba, one of the known RORs target genes, was reduced by the
selective and speciﬁc liver RORa deletion (Supplementary Fig. 1B). The
expression of other RORs target genes (i.e. Rev-erbb, Pparg, Cyp7b1,
and Lxra) was not affected by the selective and speciﬁc liver RORa
deletion (Supplementary Fig. 1B).
To further conﬁrm a speciﬁc hepatocyte RORa deletion, we isolated
primary hepatocytes from RORaLKO mice and littermate RORaﬂ/ﬂ
mice. Analyses of Rora expression by qRT-PCR as well as RORa
protein levels by Western blotting, conﬁrmed a speciﬁc RORahis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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hepatocyte deletion in RORaLKO mice compared to littermate RORaﬂ/
ﬂ mice (Supplementary Figs. 1CeD). Mice with a speciﬁc liver RORa
deletion displayed a normal fertility and fecundity generating an
equal number of male and female pups during RORaLKO and RORaﬂ/
ﬂ cross-breading.
3.2. RORa hepatic deletion does not affect glucose and lipid
metabolism in mice fed chow diet
Weight gain was monitored of 8-week-old male RORaLKO and litter-
mate RORaﬂ/ﬂ mice on chow diet for 12 weeks. We did not observe any
signiﬁcant differences in weight gain (Figure 2A), whole body adiposity
determined by MRI (Figure 2B) or liver, WAT, spleen and cecum
weights (Figure 2C). Liver RT-qPCR analysis as well as liver lipid
measurements did not reveal any differences in lipid metabolism
genes nor in cholesterol, cholesteryl ester or triglyceride levels be-
tween RORaLKO and RORaﬂ/ﬂ littermates (Figure 2D and
Supplementary Fig. 2).Figure 3: RORa hepatic deletion does not affect glucose and lipid metabolism in mic
weights (C), liver cholesterol, cholesteryl esters, triglycerides levels (D), fasting glucose (E)
in RORaﬂ/ﬂ and RORaLKO male mice fed 12 weeks WSD (n ¼ 8e12 mice per group). Da
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glucose-, insulin-, and pyruvate tolerance tests did not demonstrate
any differences between RORaLKO and RORaﬂ/ﬂ littermates
(Figure 2EeI). Similar ﬁndings where obtained for female mice (see
Supplementary Fig. 3).
Taken together, our ﬁndings suggest that hepatocyte RORa deletion
does not affect glucose and lipid metabolism on chow diet neither in
males nor in females.
3.3. RORa hepatic deletion does not affect glucose and lipid
metabolism in mice fed Western style diet
To further study the effect of RORa on metabolic associated disorders,
we fed 8-week-old RORaLKO and littermate RORaﬂ/ﬂ male mice with a
WSD for 12 weeks. We did not observe any signiﬁcant differences in
weight gain (Figure 3A), whole body adiposity measured with MRI
(Figure 3B) or liver, WAT, spleen or cecum weights (Figure 3C) sug-
gesting that RORa does not affect diet-induced obesity. Liver RT-qPCRe fed western-style diet (WSD). Body weight (A), body composition (B), relative organ
and insulin levels (F) intraperitoneal glucose (G) insulin (H) and pyruvate (I) tolerance test
ta are plotted as mean e SEM.
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Brief Communicationanalysis as well as liver lipid measurements did not reveal any dif-
ferences in in lipid metabolism genes nor in cholesterol, cholesteryl
esters or triglyceride levels between RORaLKO and RORaﬂ/ﬂ littermates
(Figure 3D and Supplementary Fig. 4).
Next, we assessed whether RORa contributes to glucose metabolism
during WSD by analyzing fasting glucose and insulin levels as well as
performing glucose-, insulin- and pyruvate tolerance tests. We did not
observe any differences between RORaLKO and RORaﬂ/ﬂ littermates
(Figure 2EeI). Similar ﬁndings were obtained when we used female
mice (see Supplementary Fig. 5).
Taken together, our ﬁndings suggest that a hepatocyte RORa deletion
does not affect glucose and lipids metabolism on WSD in both males
and females.4. DISCUSSION
NRs have been shown to play a crucial role in the regulation of glucose
and lipid metabolism. Evidences from the RORa whole body knockout
(Staggerer) mice have pointed towards RORa as a potential molecular
target for the treatment of metabolic diseases [14e16]. However, the
improved metabolic phenotype of Staggerer mice is highly affected by
the staggering phenotype induced by the cerebellum RORa deletion
[14,15], thus it is difﬁcult to evaluate the role of RORa in metabolic
active tissues, such as the liver. Here, by generating a liver speciﬁc
RORa knockout mouse model, we did not detect any effects of RORa
liver deletion on glucose or lipids metabolism on chow diet or after a
WSD exposure.
Our data are in contrast with recent published data that showed that
liver-speciﬁc ablation of RORa dramatically worsens metabolic proﬁles
in mice eg. increased adiposity, liver fat accumulation, inﬂammation,
and hepatic insulin resistance, when mice are fed a high fat diet
[20,21]. Several factors should be taken into account when comparing
the discrepancy between the distinct phenotype reported by other
groups and our present study. First, we targeted RORa exon 3 while
the Cre-lox system used by others targeted exon 4 and 4e5, leaving
the exon 3 that encodes the beginning of the DNA binding domain.
Although the stability of potentially produced recombinant proteins,
which in our experience usually is low, we cannot exclude that the
generation of different truncated proteins containing a portion of the
DNA binding domain may explain some of the divergent results be-
tween the studies. Importantly, we demonstrated an almost complete
elimination of RORa in hepatocytes similar to other groups and also a
signiﬁcant effect on some of the known RORa target genes
[20,21,27,28]. Second, we challenged our mice with WSD while other
reports used HFD. Importantly, it has been well-documented that,
despite containing fewer calories, WSD induces more pronounced
steatosis and liver inﬂammation compared with HFD [29,30]. Thus, it
may be plausible that in our model, the effect of WSD on steatosis and
inﬂammation overwhelms the effect of RORa liver deletion.
In support to our ﬁndings Zhang et al. recently reported that the single
knockout of RORa or RORg in hepatocyte has almost no effect on liver
gene expression while the double deletion of both RORa and RORg in
hepatocytes has a substantial impact on gene expression proﬁles,
increases lipogenesis and therefore predisposes to HFD-induced
steatosis [31]. RORa and RORg bind to the same response element
and are both highly expressed in liver. Thus, deletion of only one of
them may not be sufﬁcient to induce a metabolic phenotype due to
their functional redundancy. In our experimental model upon deletion
of RORa, we observed a trend towards increased Rorc expression,
which may be a compensation for the lack of RORa activity. Taken86 MOLECULAR METABOLISM 23 (2019) 82e87  2019 The Authors. Published by Elsevier GmbH. T
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Moreover, it is known that RORa is a clock gene involved in circadian
rhythm regulation [31,32]. In an attempt to reduce experimental
variation all metabolic phenotyping was performed at the same time of
the day. Thus we cannot exclude that the discrepancy between our
data and previous published data may be due to differences in
experimental set up such as time of analyses.
5. CONCLUSIONS
In conclusion, our data show that the deletion of RORa in the liver does
not affect glucose or lipid metabolism during WSD in mice. Further
studies testing the role of liver RORa or the double RORa and RORg
deletion in different dietary settings are needed to further elucidate the
role of RORa on obesity and metabolic associated disorders.
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